Influenza A H5N1 (Avian Flu) Hemagglutinin / HA ELISA Pair Set

Details for Product No. ABIN2010175, Supplier: Log in to see
Antigen
  • Hemagglutinin
  • hemagglutinin
  • temporal expression: early/late
  • ha
  • ACIAD2784
  • HA
  • A56R
Reactivity
Influenza Virus
Host
Mouse
Conjugate
Biotin
Method Type
Sandwich ELISA
Application
ELISA
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Purpose The H5N1 (avian flu) hemagglutinin ELISA Pair Set is for the quantitative determination of hemagglutinin.
This ELISA Pair Set contains the basic components required for the development of sandwich ELISAs.
The Sino ELISA Pair Set is a solid phase sandwich ELISA (Enzyme-Linked Immunosorbent Assay).
Detection Method Colorimetric
Specificity This H5N1 HA / Hemagglutinin ELISA Pair Set (SEK002) can quantificationally detect Anhui-HA (A/Anhui/1/2005), Indonesia-HA (A/Indonesia/5/2005), and Vietnam-HA (A/Vietnam/1194/2004).
And it can also react with Turkey-HA (A/turkey/Turkey/1/2005) and Qinghai-HA (A/bar-headed goose/Qinghai/14/2008).
Cross-Reactivity (Details) This H5N1 HA / Hemagglutinin ELISA Pair Set (SEK002) can quantificationally detect Anhui-HA(A/Anhui/1/2005) , Indonesia-HA (A/Indonesia/5/2005) , and Vietnam-HA (A/Vietnam/1194/2004). And it can also react with Turkey-HA (A/turkey/Turkey/1/2005) and Qinghai-HA (A/bar-headedgoose/Qinghai/14/2008).
Sensitivity 78.125 pg/mL
Characteristics Capture Antibody: 0.5 mg/mL of mouse anti-H5N1 hemagglutinin monoclonal antibody. Dilute to a working concentration of 0.5 μg/mL in PBS before coating.

Detection Antibody: 0.5 mg/mL biotinylated rabbit anti-H5N1 hemagglutinin polyclonal antibody. Dilute to a working concentration of 1.5 μg/mL in detection antibody dilution buffer before use.

Standard: Each vial contains 150 ng of recombinant H5N1 hemagglutinin. Reconstitute with 1 mL detection antibody dilution buffer. A seven-point standard curve usi ng 2-fold serial dilutions in sample dilution buffer, and a high standard of 5000 pg/mL is recommended.

Sensitivity: The minimum detectable dose of H5N1 hemagglutinin (HA) was determined to be approximately 78.125 pg/mL. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard.
Components
  • Capture Ab
  • Detection Ab
  • Standard
Material not included CBS - 0.05 M
Na2CO3 - 0.05 M
NaHCO3, pH 9.6, 0.2 μm filtered
TBS - 25 mM
Tris, adjust pH to 7.4 by HCl
Wash Buffer - 0.05 % Tween20 in TBS, pH 7.2 - 7.4
Blocking Buffer - 5 % BSA in Wash Buffer
Sample dilution buffer - 0.5 % BSA in wash buffer, pH 7.2 - 7.4, 0.2 μm filtered
Detection antibody dilution buffer - 0.5 % BSA in wash buffer, pH 7.2 - 7.4, 0.2 μm filtered
Substrate Solution: To achieve best assay results, fresh substrate solution is recommended Substrate stock solution - 10 mg/mL TMB (Tetramethylbenzidine ) in DMSO Substrate dilution buffer - 0.05 M Na2HPO4 and 0.025 M citric acid , adjust pH to 5.5
Substrate working solution - For each plate dilute 250 μL substrate stock solution in 25 mL substrate dilutionbuffer and then add 80 μL 0.75 % H2O2 , mix it well
Stop Solution - 2 N H2SO4
Alternative Name HA
Background Influenza (flu) is a viral respiratory infection in mammals and birds. This virus is divided into three main types (A, B andC) . Influenza A is found in a wide variety of mammalian and avian species and is associated with the major humanpandemics. Influenza B is largely confined to humans and became unexpectedly prevalent in humans during 2000-2002. Influenza C infects humans, dogs and pigs and generally causes only mild upper respiratory tract infection. However, influenza A and B viruses cause a wide spectrum of severe disease including lower respiratory, tract infection, pneumonia and encephalitis. Influenza A is further divided into subtypes based on antigenic differences in themembrane proteins hemagglutinin (HA) and neuraminidase (NA) . 16 HAs (H1-H16) and 9 NA (N1-N9) had beenidentified. While different combinations of the two antigens appear more frequently in some groups of birds than others, only few subtypes have established themselves in humans (HA:H1, H2, and H3, NA: N1 and N2) . Sustained, widespread highly pathogenic avian influenza (HPAI) H5N1 epidemics represent a significant public healthhazard because they not only cause mortality in poultry but also increase the risk of a human influenza pandemic. In1997, the first case of human infected H5N1 was reported in Hongkong, China. Avian influenza have broken thespecies barrier and made heavy threaten to human health. In the process of epidemic, more than 100 countries hadfound more than 400 human avian influenza infected cases, within 262 patients dead. Since two human-to-humantransmission cases were reported in China, controlling the interspecies transmission of avian influenza is of criticalimportance. At least 4 major antigenic groups of H5N1 viruses currently in circulation have caused infection in humans. The recentemergence and development of the unique antigenic FJ-like virus (clade 2. 3. 4) in Asia, the continuous circulation andexpansion of Qinghai-like virus (clade 2. 2) in Europe, the Middle East, and Africa, and the persistent prevalence ofclade 2. 1 viruses in Indonesia, and classic Clade 1 in Vietnam and Hong Kong. Hemagglutinin (HA) , which binds to sialic acid (SA) -containing receptors on host cells, is the protein that producesneutralizing antibodies. Hemagglutinin plays a major role in the determination of host range restriction and virulencebecause human influenza HA preferentially binds to SA-α-2, 6 while avian influenza HA preferentially binds to SA-α-2, 3. The cleavage of HA into two disulfide-linked subunits, HA1 and HA2, is a prerequisite for initiating infection. Usually HAis restricted to be cleaved at respiratory tracts by limited proteases. Highly pathogenic avian influenza contains a stretchof basic residues adjacent to the HA cleavage site, enabling its HA to be cleaved by a wide range of proteases withubiquitous tissue distributions. This process permits productive virus replication in organs outside of the respiratory andgastrointestinal tracts, including the brain, resulting in widespread disease and high mortality rates.
Application Notes 50 μL of streptavidin conjugated to horseradish-peroxidase. 1:2000 Dilution in detection antibody dilution buffer before use.
Comment

This H5N1 HA / Hemagglutinin ELISA Pair Set (SEK002) can quantificationally detect Anhui-HA (A/Anhui/1/2005), Indonesia-HA (A/Indonesia/5/2005), and Vietnam-HA (A/Vietnam/1194/2004).
And it can also react with Turkey-HA (A/turkey/Turkey/1/2005) and Qinghai-HA (A/bar-headed goose/Qinghai/14/2008).

Protocol The H5N1 (avian flu) hemagglutinin ELISA Pair Set is for the quantitative determination of hemagglutinin.
This ELISA Pair Set contains the basic components required for the development of sandwich ELISAs.
The ELISA Pair Set is a solid phase sandwich ELISA (Enzyme-Linked Immunosorbent Assay). It utilizes a monoclonal antibody specific for hemagglutinin coated on a 96-well plate. Standards and samples are added to the wells, and any hemagglutinin present binds to the immobilized antibody. The wells are washed and a biotinylated rabbit anti-hemagglutinin polyclonal antibody is then added, producing an antibody-antigen-antibody "sandwich". To produces color in proportion to the amount of hemagglutinin present in the sample strepavidin-HRP and TMB substrate solution are loaded. The absorbances of the microwell are read at 450 nm.
Reagent Preparation
  1. Dilute the capture antibody to the working concentration in CBS. Immediately coat a 96-well microplate with 100 μL per well of the diluted capture antibody. Seal the plate and incubate overnight at 4 °C.
    2. Aspirate each well and wash with at least 300 μL wash buffer, repeating the process two times for a total of three washes. Complete removal of liquid at each step is essential for good performance. After the last wash, remove any remaining wash buffer by inverting the plate and blotting it against clean paper towels.
    3. Block plates by adding 300 μL of blocking buffer to each well. Incubate at room temperature for a minimum of 1 hour.
    4. Repeat the aspiration/wash as in step 2. The plates are now ready for sample addition.
Assay Procedure
  1. Add 100 μL of sample or standards in sample dilution buffer per well. Seal the plate and incubate 2 hours at roomtemperature.
    2. Repeat the aspiration/wash as in step 2 of plate preparation.
    3. Add 100 μL of the detection antibody, diluted in antibody dilution buffer, to each well. Seal the plate and incubate 1hour at room temperature.
    4. Repeat the aspiration/wash as in step 2 of plate preparation.
    5. Add 100 μL of Streptavidin-HRP to each well. Incubate for 1 hour at room temperature.
    6. Repeat the aspiration/wash as in step 2 of plate preparation.
    7. Add 200 μL of substrate solution to each well. Incubate for 20 minutes at room temperature (if substrate solutionis not as requested, the incubation time should be optimized). Avoid placing the plate in direct light.
    8. Add 50 μL of stop solution to each well. Gently tap the plate to ensure thorough mixing.9. Determine the optical density of each well immediately, using a microplate reader set to 450 nm.
Calculation of Results

Calculate the mean absorbance for each set of duplicate standards, controls and samples. Subtract the mean zero standard absorbance from each. Construct a standard curve by plotting the mean absorbance for each standard on the y-axis against the concentration on the x-axis and draw a best fit curve through the points on the graph. To determine the concentration of the unknowns, find the unknowns' mean absorbance value on the y-axis and draw a horizontal line to the standard curve. At the point of intersection, draw a vertical line to the x-axis and read the concentration. If samples have been diluted, the concentration read from the standard curve must be multiplied by the dilution factor. Alternatively, computer-based curve-fitting statistical software may also be employed to calculate the concentration of the sample.

Restrictions For Research Use only
Format Liquid
Precaution of Use The Stop Solution suggested for use with this Pair Set is an acid solution. Wear eye, hand, face, andclothing protection when using this material.
Handling Advice Avoid repeated freeze-thaw cycles.
Storage 4 °C,-20 °C,-80 °C
Storage Comment Capture Antibody: Aliquot and store at -20°C to -80°C for up to 6 months from date of receipt. Avoid repeated freeze-thaw cycles.

Detection Antibody: Aliquot and store at -20°C to -80°C for up to 6 months from date of receipt. Avoid repeated freeze-thaw cycles.

Standard: Store lyophilized standard at -20°C to -80°C for up to 6 months from date of receipt. Aliquot and store the reconstituted Standard at -80°C for up to 1 month. Avoid repeated freeze-thaw cycles.

Streptavidin-HRP: Store at 4°C and protect it from prolonged exposure to light. DO NOT FREEZE! It is stable for up to 6 months from date of receipt.
Expiry Date 6 months
Supplier Images
 image for Influenza A H5N1 (Avian Flu) Hemagglutinin / HA ELISA Pair Set (ABIN2010175) Influenza A H5N1 (Avian Flu) Hemagglutinin / HA ELISA Pair Set
Product cited in: Tao, Chen, Meng, Chen, Li, Liu, Zheng, Wang: "Enhanced protective efficacy of H5 subtype influenza vaccine with modification of the multibasic cleavage site of hemagglutinin in retroviral pseudotypes." in: Virologica Sinica, Vol. 28, Issue 3, pp. 136-45, 2013 (PubMed).